Delivery Order SPE2DB20D1100-SPE2DB23FC7W8

Award Date 7/26/23
Potential Completion Date 7/27/23
Potential Value $65
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $158,000 delivery order by the Defense Logistics Agency to provide Buprenorphine 15 mcg/hr patches. The order is placed against an existing DLA pharmaceuticals contract vehicle and will be fulfilled by Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in September 2023. No subcontractors or set aside designations were identified. This order supports the DLA's...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $64,860 firm fixed price delivery order by the Defense Logistics Agency to provide Buprenorphine 5 mcg/hr patches. The order is being fulfilled under DLA's pharmaceuticals and medical/surgical supply schedule, and performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from August 28-29, 2023. As the prime contractor, Amerisourcebergen will deliver the...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $64,860 delivery order by the Defense Logistics Agency to provide Buprenorphine 5 mcg/hr patches. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania by September 8, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is placed against an existing DLA-managed contract vehicle. Amerisourcebergen will...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $53,860 delivery order by the Defense Logistics Agency to provide Buprenorphine 10 mcg/hr patches. The firm fixed price order is for a one-day period of performance in Conshohocken, Pennsylvania under the DLA's pharmaceutical products and services contract vehicle. As the prime contractor, Amerisourcebergen will deliver the opioid addiction treatment patches without involving major subcontractors....
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $57,970 delivery order against the Defense Logistics Agency's Pharmaceutical Prime Vendor contract to provide buprenorphine 5 mcg/hr patches. The firm fixed price order requires delivery to a location in Conshohocken, Pennsylvania within a one day period beginning on September 7, 2023. The Defense Logistics Agency will utilize these transdermal patches to support treatment programs for opioid...
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $508,650 delivery order by the Defense Logistics Agency to provide Buprenorphine 15 mcg/hr patches. The firm fixed price contract will be performed in Conshohocken, Pennsylvania over a one day period beginning on August 8, 2023. No set aside designation or additional context was provided regarding the Defense Logistics Agency's programs or vehicle contracts. The single delivery order is to a...
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $64,860 delivery order by the Defense Logistics Agency to provide Buprenorphine 5 mcg/hr patches. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania within a one day period beginning on September 13, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues orders under various...
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $296,760 delivery order by the Defense Logistics Agency to provide Buprenorphine 20 mcg/hr patches. The firm fixed price contract runs from September 1-5, 2023 and calls for the patches to be delivered to a location in Conshohocken, Pennsylvania. As the DLA handles procurement for the Department of Defense, these patches will likely be used to support treatment programs for opioid use disorder...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $852.58 firm fixed price delivery order by the Defense Logistics Agency to provide 4562086970 Buprenorphine 15 mcg/hr patches for the period of September 7-8, 2023. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were identified. This delivery order was issued under an existing DLA...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $1,143.50 to supply Buprenorphine 7.5 mcg/hr patches. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical product to the stated place of performance in Conshohocken, Pennsylvania by the completion date of October 27, 2023. No set-aside designation was applied to this award issued against an existing indefinite delivery contract held...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB23FC7W8
    Delivery Order

Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $65,000 firm fixed price delivery order by the Defense Logistics Agency to provide Buprenorphine 5 mcg/hr patches. The order is associated with DLA's pharmaceutical prime vendor contract and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in late July 2023. No subcontractors or set aside designations were indicated. This order supports DLA's mission to procure pharmaceuticals and medical supplies for the U.S. military and is consistent with DOD requirements for opioid addiction treatment medications.

Generated 12/24/23, 1:31 AM